6 unchanged sentences
Internal control over financial reporting is a process designed under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America.
+Added: Our independent registered public accounting firm, Deloitte & Touche LLP, has issued an attestation report on our internal control over financial reporting that is included in this Annual Report on Form 10-K.
As of December 31, 2022, our management assessed the effectiveness of our internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework (2013).
Based on this assessment, management, under the supervision and with the participation of our principal executive officer and principal financial officer, concluded that, as of December 31, 2022, our internal control over financial reporting was effective.
+Added: Our independent registered public accounting firm, Deloitte & Touche LLP, has audited the effectiveness of our internal control over financial reporting as of December 31, 2022, as stated in their report which is included in this Annual Report on Form 10-K.
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
77 unchanged sentences
Harmony Biosciences Holdings, Inc.
−Removed: 2020 Incentive Award Plan
−Removed: August 21, 2020
+Added: 2020 Incentive Award Plan, as amended by the First Amendment to the Plan, dated March 24, 2022 .
Form of Option Agreement under Harmony Biosciences Holdings, Inc.
9 unchanged sentences
August 11, 2020
+Added: Acknowledgment and Release Agreement, dated January 20, 2023, by and between Harmony Biosciences Holdings, Inc.
Form of Indemnification Agreement between Harmony Biosciences, LLC and each director and executive officer.
10 unchanged sentences
August 11, 2020
+Added: Promotion Letter Agreement, dated January 23, 2023, by and between Harmony Biosciences Holdings, Inc.
+Added: and Jeffrey M.
Offer Letter, dated September 8, 2017, by and between Harmony Biosciences, LLC and Andrew Serafin.
40 unchanged sentences
HARMONY BIOSCIENCES HOLDINGS, INC.
−Removed: President, Chief Executive Officer and Director
+Added: /s/ Jeffrey M.
+Added: Interim Chief Executive Officer
February 21, 2023
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:
−Removed: President, Chief Executive Officer, and Director
+Added: /s/ Jeffrey M.
+Added: Interim Chief Executive Officer
February 21, 2023
6 unchanged sentences
/s/ Jeffrey S.
−Removed: Chairman of the Board
+Added: Executive Chairman of the Board
February 21, 2023
15 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.